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Backgroud: The stem bark of Kalopanax pictus (KP) has 
been used in traditional medicine to treat rheumatoidal ar-
thritis, neurotic pain and diabetes mellitus in China and 
Korea. In this study, the mechanism responsible for anti-in-
flammatory effects of KP was investigated. Methods: We ex-
amined the effects of KP on NO production, nitric oxide syn-
thase (iNOS) and HO-1 expression, NF-κB, Nrf2 and 
MAPK activation in mouse peritoneal macrophages. Results: 
The aqueous extract of KP inhibited LPS-induced NO secre-
tion as well as inducible iNOS expression, without affecting 
cell viability. KP suppressed LPS-induced NF-κB activation, 
phosphorylation and degradation of IκB-α, phosphor-
ylation of extracellular signal-regulated kinase 1/2 (ERK1/2) 
and c-Jun N-terminal kinase (JNK). Furthermore, KP in-
duced HO-1 expression and Nrf2 nuclear translocation. 
Conclusion: These results suggest that KP has the inhibitory 
effects on LPS-induced NO production in macrophages 
through NF-κB suppression and HO-1 induction.
[Immune Network 2010;10(6):212-218]
INTRODUCTION
Kalopanax  pictus  (KP)  NAKAI  (Araliaceae)  is  distributed  in 
Korea, Japan, and China. The stem bark of KP has been used 
in traditional medicine to treat rheumatoidal arthritis, neurotic 
pain and diabetes mellitus (1). The constituents such as sap-
onins,  polyacetylenes,  phenylpropanoid  glycosides,  lignans, 
and simple phenolic glycosides have been isolated from this 
plant  (2).  Kalopanaxsaponin  A,  the  constituent  of  KP,  has 
been reported to inhibit iNOS, COX-2 expression, and TNF-al-
pha release in vitro (1). However, the underlying mechanism 
of  KP  function  has  remained  to  be  characterized  so  far.
    Nitric oxide (NO) is a free radical with multiple effects on 
various organ systems. The most prominent physiological ac-
tions of NO as a biological mediator include cGMP-dependent 
vasodilation, neural communication, host defense, inflamma-
tion, immune suppression and blood clotting (3). NO is pro-
duced in physiological and pathophysiological conditions by 
NO synthase (NOS), and inducible NOS (iNOS) is induced by 
inflammatory  cytokines  and/or  bacterial  lipopolysaccharide 
(LPS)  in  various  cell  types  including  macrophages.  A  large 
amount of NO, particularly synthesized by iNOS, induces an 
inflammatory response to inhibit the growth of invading mi-
croorganisms  and  tumor  cells. This strong inflammatory  re-
sponse to foreign cells could also cause further damage for 
the neighboring cells and tissues of the host. Therefore iso-
zyme specific inhibitors of NOS are essential for therapeutic 
purposes  and  drugs  that  specifically  inhibit  iNOS  could  be 
useful  in  treating  diseases  mediated  by  NO  overproduction 
(4). A major transcription factor that regulates iNOS gene ex-
pression is NF-κB. In unstimulated cells, NF-κB is present 
in the cytosol bound to the inhibitory protein I kappa B (IκB). 
I n  r e s p o n s e  t o  s t i m u l a t i o n  s u c h  a s  L P S ,  I κB s  a r e  r a p i d l y  
ubiquitinated and degraded by 26S proteasome complex. The Heme Oxygenase-1 Induction and NF-κB Suppression by Kalopanax pictus
Soo Young Bang, et al.
213 IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 6 December 2010
free NF-κB dimers translocate to the nucleus and stimulate 
target genes expression. The critical event which triggers the 
degradation  of  IκBs  is  their  stimulus-dependent  phosphor-
ylation at two serine residues (Ser32 and 36) that are located 
within  their  conserved  N-terminal  regulatory  region.
    Heme oxygenase-1 (HO-1) is a ubiquitous stress-inducible 
enzyme that catalyzes the oxidative degradation of free heme. 
HO-1 cleaves heme to form carbon monoxide (CO), iron and 
biliverdin (BV), the latter being subsequently converted into 
bilirubin (5). HO-1 expression is up-regulated in response to 
various inflammatory stimuli, and this is associated with re-
duced inflammation. The anti-inflammatory effect of HO-1 is 
d u e  t o  t h e s e  b y - p r o d u c t s  o f  H O - 1  a c t i v i t y .  C O  i s  t h e  m o s t  
responsible for anti-inflammatory  action  and  suppresses  the 
production of tumor necrosis factor-α (TNF-α), interleukin-1β 
(IL-1β), and macrophage inflammatory protein-1, iNOS and 
cyclo-oxygenase-2 (COX-2) (6,7). BV has the anti-inflamma-
tory effects on organ transplantation including decreased leu-
kocyte infiltration, less T cell proliferation, and extended sur-
vival of allogeneic heart transplants (8). It reduced production 
of the pro-inflammatory cytokines and enhanced the anti-in-
flammatory cytokines in rat model (9). HO-1 gene expression 
is  regulated  by  various  stimuli  and  transcription  factors. 
Above all, nuclear factor E2-related factor 2 (Nrf2) mainly reg-
ulates HO-1 gene expression via various intracellular signaling 
molecules including phosphatidylinositol 3-kinase (PI3K)/Akt 
pathway and mitogen-activated protein kinase (MAPK) path-
way (10). In basal condition, cytoplasmic Nrf2 is associated 
w i t h  K e l c h - l i k e  E C H  a s s o c i a t e d  p r o t e i n  1  ( K e a p 1 )  a n d  d e -
graded via ubiquitination. Numerous prooxidant stimuli cause 
dissociation of Nrf2 from Keap1, which permits subsequent 
nuclear translocation of Nrf2. In nucleus, Nrf2 binds to anti-
oxidant response element (ARE) or electrophile responsive el-
ement  (EpRE)  of  various  antioxidant  enzymes  including 
HO-1, NAD(P)H:quinone oxidoreductase-1 (NQO1), and su-
p e r o x i d e  d i s m u t a s e  ( S O D )  ( 1 1 ) .
    In this study, we investigated the effects of KP on NF-κB 
activation and MAPKs activities which have been known to 
regulate NF-κB in mouse peritoneal macrophages. We also 
examined whether KP upregulate HO-1 expression which is 
responsible  for  anti-inflammatory  effect.
MATERIALS AND METHODS
Preparation of extract
The stem bark of KP was purchased from a local herb store, 
Kwang Myoung Herb Medicine (Pusan, Korea) in April 2005. 
The roots were identified and authenticated by Professor W. 
S .  K o ,  C o l l e g e  o f  O r i e n t a l  M e d i c i n e ,  D o n g e u i  U n i v e r s i t y  
(Pusan, Korea). A voucher specimen (number KP-05-04) has 
been  deposited  at  the  Department  of  Molecular  Biology, 
Pusan National University, Busan, Korea. The dry roots (300 
g) were extracted with distilled water at 100
oC for 4 h. The 
extract  was  filtered  through  0.45μm  f i l t e r  a n d  f r e e z e - d r i e d 
(yield, 27 g) and kept at 4
oC. The dried extract was dissolved 
in phosphate buffered saline (PBS) and filtered through 0.22
μm  filter  before  use.
Macrophage culture
C57BL/6  mice  purchased  from  Dae  Han  Laboratory  Animal 
Center (Korea) were used between 8 to 12 weeks of age (25
∼30 g). Thioglycollate (TG) broth (Brewer, DIFCO, Detroit, 
MI)-elicited macrophages were harvested 3 days after intra-
peritoneal injection of 2.5 ml TG into mice and isolated as 
reported  previously  (12).  Murine  macrophage  RAW  264.7 
cells were maintained in Dulbecco’s modified Eagle’s medium 
supplemented  with  glutamine  (1  mM)  and  10%  FBS.
Measurement of nitrite concentration
NO synthesis in cell cultures was measured by a microplate 
assay method. To measure nitrite, 100μl aliquots  were  re-
moved  from  conditioned  medium  and  incubated  with  an 
equal volume of the Griess reagent (1% sulfanilamide/0.1% 
N-(1-naphthyl)-ethylenediamine dihydrochloride/2.5% H3PO4) 
at room temperature for 10 min. Nitrite concentration was de-
termined  by  measuring  the  absorbance  at  540  nm  with  a 
Vmax 96-well  microplate spectrophotometer  (Molecular  De-
v i c e s ,  M e n l o  P a r k ,  C A ) .  T h e  s o d i u m  n i t r i t e  w a s  u s e d  a s  a  
standard.
Cell viability assay
The cytotoxicity of KP was assessed using the microculture 
tetrazolium  (MTT)-based  colorimetric  assay.  The  remaining 
cells after Griess reaction were used for MTT assay. 5μl of 
MTT solution (5 mg/ml) was added to each well (final con-
centration  is  62.5μg/ml).  After  incubation  for  3  h  at  37
oC 
and 5% CO2, the supernatant was removed and the formed 
formazan crystals in viable cells were solubilized with 150μl 
of DMSO. The absorbance of each well was then read at 570 
nm  using  microplate  reader.Heme Oxygenase-1 Induction and NF-κB Suppression by Kalopanax pictus
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Preparation of nuclear extract and eletrophoretic 
mobility shift assay
Nuclear extracts were prepared as described previously (12). 
Eletrophoretic mobility shift assay (EMSA) of nuclear extracts 
was  performed  according  to  the  manufacturer’s  instructions 
(Promega,  Madison,  WI)  with  some  modifications.  In  brief, 
the probe consisted of a double-stranded oligonucleotide con-
taining the consensus binding sequence for NF-κB (5’-AGTT-
GAGGGGACTTTCCCAGGC-3’,  Promega,  Madison,  WI)  was 
end-labeled with [γ-
32P]-ATP (3,000 Ci/mmol at 10μCi/ml) 
using  T4  polynucleotide  kinase.  Nuclear  extracts  were  in-
cubated with gel shift binding buffer (10 mM HEPES, pH 7.9, 
5 0  m M  K C l ,  0 . 2  m M  E D T A ,  2 . 5  m M  D T T ,  1 0 %  g l y c e r o l ,  
0.05% NP-40, 0.25 mg/ml poly dI/poly dC, protease inhibitor 
cocktail) for 10 min at room temperature and then the mix-
ture was incubated with 
32P-labeled probe for 20 min at room 
temperature. The incubation mixture was loaded onto non-
denaturating gel and run in 0.25× Tris/borate/EDTA buffer. 
Gels  were  dried  and  exposed  to  X-ray  film  at  −70
oC.
Western blot analysis
The cells were washed with phosphate buffered saline (PBS) 
three times and scraped off and lysed with lysis buffer (1% 
Triton X-100, 1% deoxycholate). Protein concentration of ly-
sates was determined and equal amounts of protein were sep-
arated electrophoretically using 10% SDS-PAGE (sodium do-
decyl  sulfate-polyacrylamide  gel  electrophoresis),  and  then 
the gel was transferred to 0.45μm nitrocellulose paper. The 
blot was incubated with anti-iNOS, IκB-α, HO-1, Nrf2, β- 
tubulin  antibody  (Santa  Cruz  Biotechnology),  anti-phospho- 
IκB-α, JNK, phospho-JNK,  ERK1/2, phospho-ERK1/2 anti-
body  (Cell  Signaling  Technology),  and  secondary  antibody 
and then detected by the enhanced chemiluminescence de-
tection  system  according  to  the  recommended  procedure 
(Amersham  Co.).
Statistical analysis
All  results  were  expressed  as  means±SE.  Each  experiment 
was repeated at least three times. Statistical significances were 
compared between each treated group and analyzed by the 
paired  Student’s  t-test.  Data  with  p＜0.05  were  considered 
statistically  significant.
RESULTS
KP inhibits NO synthesis and iNOS expression in macro-
phages
To investigate the anti-inflammatory effect of KP, we exam-
ined the effect of KP on NO synthesis. TG-elicited mouse per-
itoneal  macrophages  were  incubated  with  KP  for  1  h  and 
stimulated with 0.1μg/ml LPS for 24 h. The amount of NO 
released into culture medium was measured by the method 
of Griess. Whereas LPS-treated cells produced a large amount 
of NO, KP suppressed NO release into culture supernatant in 
a dose-dependent manner (Fig. 1A). To determine whether 
the decreased nitric oxide synthesis is correlated with iNOS 
expression, we analyzed the amount of iNOS by Western blot 
analysis.  TG-elicited  mouse  peritoneal  macrophages  were 
treated with KP as mentioned above. The level of iNOS was 
dramatically  reduced  by  KP  in  a  dose-dependent  manner 
(Fig. 1B). On the other hand, cell viability was not affected 
by  KP  as  measured  by  MTT  assay  (Fig.  1C).  These  results 
suggest that KP inhibits NO release by affecting the iNOS ex-
p r e s s i o n  l e v e l  w i t h o u t  a ffecting  cell  viability.
KP suppresses NF-κB activity and phosphorylation/ 
degradation of IκB-α in macrophages
Since iNOS promoter contains 2 binding sites for transcription 
factor NF-κB and NF-κB plays a critical role in LPS-induced 
i N O S  e x p r e s s i o n ,  w e  i n v e s t i g a t e d  w h e t h e r  K P  s u p p r e s s e s  
iNOS  expression  through  the  regulation  of  NF-κB  activity. 
TG-elicited  mouse  peritoneal  macrophages  were  incubated 
with KP for 1 hr and stimulated with 0.1μg/ml LPS for 30 
minutes. A low level of NF-κB/DNA complex was observed 
in unstimulated macrophages, while a large quantity of NF-κB/ 
DNA complex was induced by LPS treatment. This increased 
NF-κB  binding  affinity  was  inhibited  by  KP  in  a  dose-de-
pendent manner (Fig. 2A). These results suggest that KP sup-
presses iNOS expression though inhibition of NF-κB activity.
    To analyze whether KP affect NF-κB signaling pathway, 
we investigated the effects of KP on upstream signaling path-
way  of  NF-κB,  that  is,  IκB-α degradation.  TG-elicited 
mouse peritoneal macrophages were pretreated with KP for 
1 h and stimulated with LPS (0.1μg/ml) for 15 min, and then 
the levels of IκB-α or phospho-IκB-α protein were exam-
ined by Western blotting. As shown in Fig. 2B, IκB-α was 
degraded in response to LPS, but KP suppressed the degrada-
tion of IκB-α in a dose-dependent manner. Incubation of 
macrophages  with  LPS  for  15  min  also  caused  significant Heme Oxygenase-1 Induction and NF-κB Suppression by Kalopanax pictus
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Figure 1. Effect of KP on the NO secretion and iNOS expression in
TG-elicited mouse peritoneal macrophages. (A) Cells were incubated 
with various concentrations of KP for 1 h and then stimulated with
0.1μg/ml LPS for 24 h at 37
oC. The amount of nitrite released was
measured by the method of Griess. Values are means±S.E. of three 
independent experiments. *p＜0.05 and 
†p＜0.01 vs LPS-treated 
group. (B) Cells were treated with KP and/or LPS as mentioned above
and equal cytosolic extracts were analyzed by Western blotting with
anti-iNOS antibody. Western blot detection of β-tubulin was 
estimated protein-loading control for each lane. (C) Cells were 
incubated with various concentration of UR in presence of 0.1μg/ml 
of LPS for 24 h. Then cell viability was measured by MTT assay as
described in Materials and Methods. Data represent the relative 
viability to control group and are expressed as the means±S.E. of 
three independent experiments.
Figure 2. Inhibitory effect of KP on NF-κB activity and phosphory-
lation/degradation of IκB-α. (A) Effect of KP on DNA binding activity
of NF-κB. TG-elicited mouse peritoneal macrophages were incubated
with various concentrations of KP for 1 h, and then stimulated with
LPS (0.1μg/ml) for 30 min. Nuclear proteins were extracted and 
assayed for NF-κB DNA binding affinity by EMSA as described in 
Materials and methods. ns, non-specific band. (B) Effect of KP on 
LPS-stimulated phosphorylation and degradation of IκB-α. Cells 
were incubated with various concentrations of KP for 1 hr, and then 
stimulated with 0.1μg/ml LPS for 15 min. Cells were harvested and 
equal cytosolic extracts were analyzed by Western blotting with anti-
IκB-α and -phospho-IκB-α. Western blot detection of β-tubulin 
was estimated protein-loading control for each lane.
phosphorylation  of  IκB-α,  but  KP  markedly  inhibited  the 
phosphorylation  of  IκB-α.  These  results  indicate  that  KP 
blocks NF-κB translocation into nucleus through suppression 
of  IκB-α phosphorylation  and  degradation.Heme Oxygenase-1 Induction and NF-κB Suppression by Kalopanax pictus
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Figure 3. Effect of KP on ERK1/2 and JNK activity in LPS-stimulated
macrophages. TG-elicited mouse peritoneal macrophages were treated
with indicated concentrations of KP for 1 h and stimulated with 0.1μ
g/ml LPS for 15 min. Equal amount of cell extracts was analyzed by 
western blotting with anti-phospho-ERK1/2 or -phospho-JNK antibody.
Western blot detection of non-phosphorylated kinases was estimated
protein-loading control for each lane.
Figure 4. Effect of KP on HO-1 expression and nuclear translocation 
of in macrophages. (A) TG-elicited mouse peritoneal macrophages 
were incubated with indicated concentrations of KP for 24 h. HO-1 
protein levels of cytosolic extracts were analyzed by Western blotting.
(B) Cells were incubated with indicated concentrations of KP for 3
h and the levels of Nrf2 in nuclear extracts were analyzed by Western 
blotting. Western blot detection of β-tubulin was estimated protein- 
loading control for each lane.
KP inhibits LPS-induced MAPK activities
To elucidate the molecular target of KP in further upstream 
signaling pathway, we examined the effect of KP on MAPKs 
activities which regulate the function of NF-κB (13). Since 
extracellular  signal-regulated  kinase1/2  (ERK1/2)  and  c-Jun 
N-terminal kinase (JNK) have been known to be phosphory-
lated  and  activated  in  response  to  LPS,  the  activities  were 
monitored  by  its  phosphorylation.  TG-elicited  mouse  peri-
toneal  macrophages  were  treated  with  indicated  concen-
t r a t i o n s  o f  K P  f o r  1  h  a n d  t h e n  s t i m u l a t e d  w i t h  0 . 1μg/ml 
LPS  for  15  min.  KP  suppressed  LPS-induced  activation  of 
ERK1/2 and JNK in a dose-dependent manner (Fig. 3), while 
the amount of kinases was unaffected by either LPS or KP 
treatment.
HO-1 expression is induced by KP in macrophages
It is known that by-products of HO-1 have anti-inflammatory 
effect. To determine whether KP exhibit anti-inflammatory ef-
fect through the induction of HO-1, HO-1 expression by KP 
was  examined.  TG-elicited  mouse  peritoneal  macrophages 
were treated with KP for 24 h. KP induced HO-1 expression 
in  a  dose-dependent  manner  (Fig.  4A).
    To  determine  whether  KP-induced  HO-1  expression  is 
caused by Nrf2 transcription factor, we examined the effect 
of KP on Nrf2 nuclear translocation. TG-elicited mouse peri-
toneal macrophages were treated with KP and cytosolic and 
nuclear  extracts  were  separately  harvested.  The  amount  of 
nuclear  Nrf2  was  increased  by  KP  in  dose-dependent  and 
time-dependent  manners,  whereas  the  amount  of  cytosolic 
N r f 2  d i d  n o t  s h o w e d  p r o m i n e n t  c h a n g e s  ( F i g .  4 B ) .
DISCUSSION
The application of medicinal herbs dates back to the begin-
ning of civilization, and interestingly, medicinal herbs are still 
routinely  used  by  most  of  world’s  population.  Over  time, 
many information has been accumulated by using these herbs 
in  practice,  and  it  is  experientially  proved  that  these  herbs 
have the effect of pain alleviation, life extension and disease 
prevention. Of these, the stem bark of KP has been used for 
different remedies and expresses specific therapeutic effects Heme Oxygenase-1 Induction and NF-κB Suppression by Kalopanax pictus
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in China and Korea. The stem bark of KP is mainly used for 
treating neuralgia, rheumatic arthritis, lumbago, furuncle, car-
buncle, wound, diarrhea and scabies (2). It has been reported 
that  hederagenin  monodesmosides  and  bisdesmosides  iso-
lated from the stem bark of KP have antimutagenic and cyto-
toxic activity (14). Kalopanaxsaponin A and pictoside A from 
the  stem  bark  of  KP  reduce  vascular  permeability  (2).  The 
other constituent of KP, α-hederin methyl ester, showed anti-
carrageenan activity in rats and antiarthritic activity in rats and 
mice  (15).  Kalopanaxsaponin  A  was  reported  to  have  an-
ti-rheumatoidal (16-19), anti-tumor (20), anti-diabetic (21), an-
tifungal (22) activities. Kalopanaxsaponins A inhibits the pro-
duction of NO, prostaglandin E2 (PGE2) and TNF-α in mac-
rophage  cell  line  RAW  264.7  (1).  In  this  study,  KP  sig-
nificantly inhibited LPS-induced NO production and iNOS ex-
pression in mouse peritoneal macrophages (Fig. 1), which is 
consistent with the results of Kim et al. (1). Because KP did 
not  show  cytotoxic  effects,  inhibition  of  iNOS  expression 
might  be  specific.  Major  transcriptional  regulators  of  iNOS 
gene are the NF-κB family of transcription factors, which are 
also key regulators of a variety of genes involved in immune 
and inflammatory responses. Since dysregulation of NF-κB 
function  is  associated  with  inflammation,  a  development  of 
drug that control NF-κB is one of promising candidates for 
the  therapeutic  strategy  in  the  treatment  of  inflammatory 
disease. Our study showed that KP significantly inhibited NF-
κB DNA binding activity in macrophages. Although it was 
reported that the combined extracts containing KP and other 
herb medicine suppress NF-κB DNA binding activity in RAW 
264.7 cells (23), the effect of KP on NF-κB activity has re-
mained to be clarified. Moreover, our study showed that KP 
suppressed not only the LPS-stimulated degradation but also 
phosphorylation of IκB-α. The phosphorylation of N-termi-
nal regulatory serines on IκB-α and IκB-α is known to 
be  catalyzed  by  IKK.  Thus,  KP  could  regulate  the  IKK 
activity. Since MAPKs have been shown to be involved in the 
LPS-mediated induction of many inflammatory genes includ-
ing iNOS gene and are important for the activation of NF-κB 
(13),  we  investigated  the  eff e c t  o f  K P  o n  E R K 1 / 2  a n d  J N K 
activation in LPS-stimulated mouse peritoneal macrophages. 
KP greatly inhibited the LPS-induced ERK1/2 and JNK after 
LPS application. These results suggest that KP inhibits LPS-in-
duced  NF-κB  activation  by  down-regulating  ERK1/2  and 
JNK.
    HO breaks down free heme made from intracellular heme- 
containing proteins. Two types of isozyme have been identi-
fied; HO-1 and 2. Whereas HO-2 is a constitutively expressed 
form, HO-1 is an inducible form that expressed by either in-
flammatory  or  oxidative  stress  (5).  Recently,  many  reports 
s h o w e d  t h a t  H O - 1  e x p r e s s i o n  i s  a s s o c i a t e d  w i t h  r e d u c e d  
inflammation. HO-1 plays a critical protective role during the 
development of intestinal inflammation (24,25). HO-1 attenu-
ates  metabolic  syndrome  in  obese  mice  (26),  LPS-induced 
lung injury (27), cardiovascular desease (28) and liver desease 
(29). HO-1-deficient mice develop increased end-organ dam-
age  and  have  increased  mortality  after  LPS  administration 
(30). Human HO-1 deficiency presents with severe hemolysis, 
asplenia, inflammation and nephritis (31). In addition, LPS-in-
duced iNOS expression is reduced by HO-1 expression (24). 
In this study, HO-1 expression was increased by KP, and nu-
clear  translocation  of  Nrf2,  a  major  transcription  factor  of 
HO-1 expression, also induced by KP. These results suggest 
that  KP  exhibit  anti-inflammatory  effect  by  suppressing  NO 
production  via  HO-1  induction.
    In conclusion, we demonstrated that KP inhibited NO re-
lease  and  iNOS  expression  in  LPS-stimulated  macrophages, 
and that these effects are mediated by inhibition of the activ-
ity of IκB/NF-κB and induction of HO-1. Our results pro-
vide a molecular basis for understanding the inhibitory effects 
of KP on endotoxin-mediated inflammation. As the effect of 
KP is mediated via inhibition of NF-κB and HO-1 induction, 
KP could be developed into potent anti-inflammatory drugs 
and be used in pathological processes in which NF-κB and 
H O - 1  a r e  i n v o l v e d .
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